tiprankstipranks
Genor Biopharma Holdings Limited (HK:6998)
:6998
Hong Kong Market
6998
Genor Biopharma Holdings Limited
RESEARCH TOOLSreports
Want to see HK:6998 full AI Analyst Report?

Genor Biopharma Holdings Limited (6998) Ratios

3 Followers

Genor Biopharma Holdings Limited Ratios

HK:6998's free cash flow for Q4 2025 was ¥0.55. For the 2025 fiscal year, HK:6998's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.00 1.00 8.74 5.41 6.61
Quick Ratio
 0.80 0.80 8.74 5.38 6.42
Cash Ratio
 0.48 0.48 8.67 5.08 6.10
Solvency Ratio
 0.26 0.25 0.10 -2.38 -2.18
Operating Cash Flow Ratio
 0.12 0.20 -1.00 -1.85 -2.22
Short-Term Operating Cash Flow Coverage
 0.24 0.42 0.00 0.00 0.00
Net Current Asset Value
¥ -551.23M¥ -551.23M¥ 929.24M¥ 984.95M¥ 1.41B
Leverage Ratios
Debt-to-Assets Ratio
 0.23 0.23 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 0.39 0.39 <0.01 <0.01 0.02
Debt-to-Capital Ratio
 0.28 0.28 <0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.09 0.09 0.00 0.00 0.00
Financial Leverage Ratio
 1.71 1.71 1.12 1.22 1.17
Debt Service Coverage Ratio
 0.50 0.68 -81.53 0.00 -235.95
Interest Coverage Ratio
 2.61 4.59 -257.28 0.00 -275.28
Debt to Market Cap
 1.08 0.32 0.00 0.00 0.00
Interest Debt Per Share
 1.24 0.97 <0.01 0.01 0.06
Net Debt to EBITDA
 0.61 0.46 205.41 2.10 2.31
Profitability Margins
Gross Profit Margin
55.55%55.36%99.35%0.00%93.83%
EBIT Margin
16.20%25.56%-34.15%0.00%-4579.24%
EBITDA Margin
28.98%38.34%-2.50%0.00%-4242.32%
Operating Profit Margin
16.20%25.56%-35.18%0.00%-4934.75%
Pretax Profit Margin
19.91%19.95%-17.04%0.00%-4597.16%
Net Profit Margin
16.01%16.05%-24.87%0.00%-4584.46%
Continuous Operations Profit Margin
16.01%16.05%-25.69%0.00%-4584.46%
Net Income Per EBT
80.41%80.45%145.97%99.54%99.72%
EBT Per EBIT
122.95%78.06%48.42%95.26%93.16%
Return on Assets (ROA)
5.93%5.89%-3.98%-46.61%-34.53%
Return on Equity (ROE)
15.81%10.09%-4.45%-56.73%-40.52%
Return on Capital Employed (ROCE)
9.02%14.10%-6.21%-58.42%-42.39%
Return on Invested Capital (ROIC)
5.81%9.09%-6.21%-58.07%-42.12%
Return on Tangible Assets
13.21%13.11%-4.31%-50.45%-37.42%
Earnings Yield
11.51%8.62%-6.15%-125.65%-61.66%
Efficiency Ratios
Receivables Turnover
 3.86 3.82 0.00 0.00 0.00
Payables Turnover
 3.37 3.35 0.02 0.00 <0.01
Inventory Turnover
 2.51 2.50 0.00 0.00 0.02
Fixed Asset Turnover
 7.22 7.15 35.44 0.00 0.08
Asset Turnover
 0.37 0.37 0.16 0.00 <0.01
Working Capital Turnover Ratio
 6.00 5.18 0.21 0.00 <0.01
Cash Conversion Cycle
 131.33 132.44 -22.54K 0.00 -31.47K
Days of Sales Outstanding
 94.56 95.47 0.00 0.00 0.00
Days of Inventory Outstanding
 145.16 145.94 0.00 0.00 17.60K
Days of Payables Outstanding
 108.39 108.97 22.54K 0.00 49.07K
Operating Cycle
 239.72 241.41 0.00 0.00 17.60K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.20 0.27 -0.24 -0.84 -1.15
Free Cash Flow Per Share
 0.16 0.24 -0.24 -0.84 -1.17
CapEx Per Share
 0.03 0.03 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.82 0.89 1.01 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 2.80 4.80 -77.79 -411.14 -44.59
Capital Expenditure Coverage Ratio
 5.63 9.47 -77.79 -411.14 -44.59
Operating Cash Flow Coverage Ratio
 0.17 0.30 -133.90 -59.42 -20.21
Operating Cash Flow to Sales Ratio
 0.11 0.19 -0.59 0.00 -36.25
Free Cash Flow Yield
15.75%8.96%-14.81%-79.40%-49.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.69 11.60 -16.27 -0.80 -1.62
Price-to-Sales (P/S) Ratio
 0.55 1.86 4.05 0.00 74.35
Price-to-Book (P/B) Ratio
 0.88 1.17 0.72 0.45 0.66
Price-to-Free Cash Flow (P/FCF) Ratio
 6.35 11.17 -6.75 -1.26 -2.01
Price-to-Operating Cash Flow Ratio
 13.17 9.99 -6.84 -1.26 -2.05
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.04 0.18 0.10 0.09
Price-to-Fair Value
 0.88 1.17 0.72 0.45 0.66
Enterprise Value Multiple
 2.51 5.32 43.39 1.13 0.56
Enterprise Value
 1.78B 4.94B -223.46M -621.64M -375.63M
EV to EBITDA
 2.51 5.32 43.39 1.13 0.56
EV to Sales
 0.73 2.04 -1.08 0.00 -23.58
EV to Free Cash Flow
 8.38 12.23 1.81 1.46 0.64
EV to Operating Cash Flow
 6.89 10.94 1.83 1.46 0.65
Tangible Book Value Per Share
 0.16 0.13 2.05 2.13 3.26
Shareholders’ Equity Per Share
 2.91 2.30 2.24 2.35 3.57
Tax and Other Ratios
Effective Tax Rate
 0.20 0.20 -0.51 <0.01 <0.01
Revenue Per Share
 1.85 1.45 0.40 0.00 0.03
Net Income Per Share
 0.30 0.23 -0.10 -1.33 -1.45
Tax Burden
 0.80 0.80 1.46 1.00 1.00
Interest Burden
 1.23 0.78 0.50 1.10 1.00
Research & Development to Revenue
 0.06 0.06 0.98 0.00 36.65
SG&A to Revenue
 0.33 0.24 0.35 0.00 8.42
Stock-Based Compensation to Revenue
 0.02 0.02 0.06 0.00 3.03
Income Quality
 0.52 0.91 2.38 0.63 0.79
Currency in CNY